Viventia Biotech generates novel human anti-cancer antibody, VB1 ...

Biotech News
AZhttp, Inc.

Annual General Meeting of Active Biotech AB

LUND, Sweden, April 20, 2007-The Annual General Meeting (AGM) of Active Biotech AB was held on April 19, 2007.




Board members Sven Andréasson, Mats Arnhög, Professor Klas Kärre, Peter Sjöstrand and Peter Ström were re-elected by the AGM. The AGM also decided to appoint Mats Arnhög as Chairman of the Board.

Magnhild Sandberg-Wollheim was elected as a new member of the Board. She is an associate professor of Neurology and Chief Medical Officer at the neurological clinic at Lund University Hospital. Magnhild Sandberg-Wollheim has forty years' experience of treating patients with multiple sclerosis and her research has largely focused on clinical, immunological and genetic problems of this disease.

Viventia Biotech generates novel human anti-cancer antibody, VB1 ...
Viventia Biotech Inc. announced that it has generated a novel, fully human anti-cancer antibody, VB1-050, and also identified the novel target for the antibody, a mutant form of the protein Glut-8. ...